fenton's reagent has been researched along with arginyl-glycyl-aspartic acid in 1 studies
| Studies (fenton's reagent) | Trials (fenton's reagent) | Recent Studies (post-2010) (fenton's reagent) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
|---|---|---|---|---|---|
| 1,891 | 1 | 843 | 4,556 | 17 | 1,799 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Han, Z; Hua, Y; Kang, X; Liu, JQ; Wang, Y; Wang, ZY; Xu, F; Zang, SQ; Zhang, C; Zhao, X | 1 |
1 other study(ies) available for fenton's reagent and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
A multifunctional AIE gold cluster-based theranostic system: tumor-targeted imaging and Fenton reaction-assisted enhanced radiotherapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Female; Ferric Compounds; Gold; Humans; Hydrogen Peroxide; Iron; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Oligopeptides; Photochemotherapy; Radiation-Sensitizing Agents; Theranostic Nanomedicine; Tissue Distribution | 2021 |